Toxicological considerations of Kampo medicines in clinical use
Authors:
- Fumio IkegamiFIFumio Ikegami
- Yuichi FujiiYFYuichi Fujii
- Tetsuo SatohTSTetsuo Satoh
- 1 May 2004
- journal article
- review article
- Published by Elsevier in Toxicology
- Vol. 198 (1-3) , 221-228
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- History of The Endocrine Effects of LicoriceExperimental and Clinical Endocrinology & Diabetes, 2002
- Panax ginsengDrug Safety, 2002
- Potential Interactions between Herbal Medicines and Conventional Drug Therapies Used by Older Adults Attending a Memory ClinicDrugs & Aging, 2002
- EXAMPLES OF INTERACTIONS BETWEEN CHINESE HERBAL MEDICINAL PRODUCTS AND ORTHODOX DRUGS2000
- Herb-drug interactionsThe Lancet, 2000
- Inhibitory Effect of Natural Furanocoumarins on Human Microsomal Cytochrome P450 3A ActivityThe Japanese Journal of Pharmacology, 2000
- Specific CYP3 A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interactionPharmacogenetics, 1997
- Effects of traditional Chinese medicines on pharmacokinetics of levofloxacinAntimicrobial Agents and Chemotherapy, 1995
- A Novel 11β-Hydroxysteroid Dehydrogenase Inhibitor Contained in Saiboku-To, a Herbal Remedy for Steroid-dependent Bronchial AsthmaJournal of Pharmacy and Pharmacology, 1994
- Effects of Shousaiko-to, Keishikashakuyaku-to and its Simultaneous Use on the Pharmacokinetics of Phenytoin in Rabbit.Japanese Journal of Hospital Pharmacy, 1993